Like IL-9, IL-18 also exhibits antitumour properties and its lower expression in CRC has been shown by Feng et al. They also observed that the upregulation of IL-18 leads to the inhibition of colon cancer cell proliferation [43]. The gene discussed is IL9; the disease is colorectal carcinoma.